Bionomics Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BNO.AX research report →
Price Chart
About the company
Established in 1996 and headquartered in Eastwood, Australia, Bionomics Limited operates as a clinical-stage biopharmaceutical firm. The company's mission is to identify and advance innovative drug treatments, primarily focusing on central nervous system (CNS) conditions and various forms of cancer. Its key experimental therapeutic, BNC210, is a negative allosteric modulator targeting the a7 nicotinic acetylcholine receptor, currently undergoing Phase 2 trials for social anxiety disorder and more advanced Phase 2b trials for post-traumatic stress disorder (PTSD).
- CEO
- Spyridon Papapetropoulos
- IPO
- 1999
- Employees
- 140
- HQ
- Eastwood, SA, AU
Get TickerSpark's AI analysis on BNO.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $13.22M
- P/E
- -0.36
- PEG
- 0.01
- P/S
- -2.04
- P/B
- 0.73
- EV/EBITDA
- -0.09
- Div Yield
- 0.00%
- Gross Margin
- 104.75%
- Op Margin
- 230.73%
- Net Margin
- 271.97%
- ROE
- -113.35%
- ROIC
- -71.97%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-434,000+97.7%
- Op Income
- $-17,892,376,000
- Net Income
- $-15,492,166,000-72936.6%
- EPS
- $-0.01+99.7%
- OCF Growth
- -3.3%
- FCF Growth
- -3.3%
- 52W High
- $0.07
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.03
- Beta
- 2.13
- RSI (14)
- 41
- Avg Volume
- 2.86M
No earnings-call transcripts are available for BNO.AX yet.
- Free Float
- 66.7%
- Shares Outstanding
- 1.47B
- Float Shares
- 980.03M
Our BNO.AX coverage
Recent articles, reports, and earnings notes.
No research on BNO.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BNO.AX report →